by Indigo | Oct 4, 2024 | 2024, News
Indigo is pleased to announce the successful completion of its annual EN ISO 13485:2016 surveillance audit, conducted by TÜV SÜD, reaffirming its certification for the design and development of biomarker sensing devices and services. This certification emphasizes the...
by Indigo | May 29, 2024 | 2024, News
Indigo has been granted U.S. Patent No. 11,992,310 for its personal health monitoring system. This revolutionary technology is designed to enhance continuous health monitoring by using a minimally invasive insertable sensor to track critical parameters like glucose...
by Indigo | Mar 1, 2024 | 2024, News
Indigo closed its SHINE clinical trial, marking a significant milestone in the development of innovative healthcare technology. The trial, designed to evaluate the longer-term stability of Indigo’s continuous multi-metabolite (‘CMM’) device, has concluded its phase...
by Indigo | Jan 31, 2024 | 2024, News
We’re absolutely thrilled to share some fantastic news with you all! Our CEO, Danaë Delbeke, has been recognized as one of the 100 Most Prominent Women in Belgian Media!This prestigious acknowledgment highlights her remarkable leadership, dedication, and...
by Indigo | Nov 30, 2023 | 2023, News
The Music4Diabetes consortium has unveiled an ambitious initiative aimed at revolutionizing Type 1 Diabetes treatment. The latest project involves the development of an implantable multi-metabolite sensor, seamlessly integrated with a continuous insulin delivery pump....
by Indigo | Oct 2, 2023 | 2023, News
Indigo’s CEO, Danaë Delbeke’s exclusive presentation on revolutionary continuous multi-metabolite monitoring (CMM®) sensor at the Life Science Intelligence Summit is now available for viewing! Catch up on the exciting insights shared by our CEO, Danaë Delbeke,...
